Standard BioTools Inc (LAB)
1.925
0.00 (0.00%)
USD |
NASDAQ |
Jun 21, 16:00
1.925
0.00 (0.00%)
Pre-Market: 20:00
Standard BioTools Free Cash Flow: -99.88M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -99.88M |
| December 31, 2023 | -46.12M |
| September 30, 2023 | -51.92M |
| June 30, 2023 | -65.47M |
| March 31, 2023 | -86.23M |
| December 31, 2022 | -93.20M |
| September 30, 2022 | -80.72M |
| June 30, 2022 | -66.05M |
| March 31, 2022 | -53.96M |
| December 31, 2021 | -57.32M |
| September 30, 2021 | -64.30M |
| June 30, 2021 | -58.04M |
| March 31, 2021 | -42.63M |
| December 31, 2020 | -28.13M |
| September 30, 2020 | -19.71M |
| June 30, 2020 | -20.67M |
| March 31, 2020 | -22.67M |
| December 31, 2019 | -37.74M |
| September 30, 2019 | -32.38M |
| June 30, 2019 | -30.75M |
| March 31, 2019 | -29.72M |
| December 31, 2018 | -25.57M |
| September 30, 2018 | -24.48M |
| June 30, 2018 | -28.76M |
| March 31, 2018 | -32.79M |
| Date | Value |
|---|---|
| December 31, 2017 | -25.71M |
| September 30, 2017 | -37.57M |
| June 30, 2017 | -44.01M |
| March 31, 2017 | -44.45M |
| December 31, 2016 | -44.20M |
| September 30, 2016 | -45.12M |
| June 30, 2016 | -43.13M |
| March 31, 2016 | -43.49M |
| December 31, 2015 | -45.38M |
| September 30, 2015 | -38.05M |
| June 30, 2015 | -35.29M |
| March 31, 2015 | -28.50M |
| December 31, 2014 | -30.03M |
| September 30, 2014 | -23.86M |
| June 30, 2014 | -15.49M |
| March 31, 2014 | -17.06M |
| December 31, 2013 | -6.277M |
| September 30, 2013 | -11.70M |
| June 30, 2013 | -13.56M |
| March 31, 2013 | -14.40M |
| December 31, 2012 | -19.86M |
| September 30, 2012 | -20.53M |
| June 30, 2012 | -19.48M |
| March 31, 2012 | -26.81M |
| December 31, 2011 | -21.22M |
Free Cash Flow Range, Past 5 Years
-99.88M
Minimum
Mar 2024
-19.71M
Maximum
Sep 2020
-52.89M
Average
-52.94M
Median
Free Cash Flow Benchmarks
| Bruker Corp | 181.10M |
| Azenta Inc | 54.97M |
| Harvard Bioscience Inc | 10.81M |
| Bionano Genomics Inc | -122.26M |
| Akoya Biosciences Inc | -55.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -62.48M |
| Cash from Investing (Quarterly) | 318.08M |
| Cash from Financing (Quarterly) | -19.73M |
| Free Cash Flow Per Share (Quarterly) | -0.2151 |
| Free Cash Flow to Equity (Quarterly) | -54.70M |
| Free Cash Flow to Firm (Quarterly) | -63.26M |
| Free Cash Flow Yield | -39.03% |